Stocks to Buy or Sell: What prime brokerages say 

— Morgan Stanley on Apollo Tyres (CMP: 278) 

Maintain Overweight, Target 329 

European enterprise continues to achieve share 

Growth in india has primarily been led by pricing as volumes are flat 

Co goals to stay because the pricing chief 

Stable pricing & declining commodity prices doubtless to supply margin tailwinds in Q3FY23 

From present 7% ranges, Mgmt targets 12-15% ROCE 

— Goldman Sachs on Sun Pharma (CMP: 1013) 

Maintain Sell, Target 830 

Expect progress momentum to proceed 

Specialty Rev led by market share beneficial properties & New product ramp as much as assist progress 

New Pdt Launches in India Biz & Improvement in Mr productiveness to assist progress 

Co expects R&D Costs to inch larger as affected person enrolments for its scientific trials choose up 

—  Nomura on Exide Industries (CMP: 187) 

Maintain Buy, Target Raised to 221 from 216  

2Q ends in line  

Steady progress to proceed; plans to speculate INR60bn in Liion plant 

increase FY23F income est. by 10% to consider larger 1HFY23 runrate 

Valuations enticing at 15.1x FY25F core EPS 

(Disclaimer: The views/recommendations/advises expressed right here on this article is solely by funding specialists. Zee Business suggests its readers to seek the advice of with their funding advisers earlier than making any monetary choice.)